Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Chen, Yen Ta ^a   Yang, Chih Chau ^a   Zhen, Yen Yi ^a   Wallace, Christopher Glenn ^c   Yang, Jenq Lin ^a   Sun, Cheuk Kwan ^d   Tsai, Tzu Hsien ^a   Sheu, Jiunn Jye ^a   Chua, Sarah ^a   Chang, Chia Lo ^a   Cho, Chung Lung ^b   Leu, Steve ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CD68 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CREATININE; CYCLINE; CYCLOSPORIN; GELATINASE B; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; HISTONE H2AX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE SYNTHASE; NITROGEN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BAX; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STROMAL CELL DERIVED FACTOR 1ALPHA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; ENZYME ACTIVITY; FLOW CYTOMETRY; HISTOPATHOLOGY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; BIOLOGICAL THERAPY; BLOOD; CYTOLOGY; ENZYMOLOGY; GENETICS; KIDNEY; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; URINE;

RATTUS;

ACUTE KIDNEY INJURY; ADIPOSE TISSUE; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOOD UREA NITROGEN; CASPASE 3; CELL- AND TISSUE-BASED THERAPY; CREATININE; CYCLOSPORINE; DNA DAMAGE; KIDNEY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878364606     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt212     Document Type: Article

References (32)

1. Long-term prognosis of acute kidney injury after acute myocardial infarction. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM, Arch Intern Med 2008 168 987 995 10.1001/archinte.168.9.987 18474763
2. Acute renal failure in the medical ICU still predictive of high mortality. Friedericksen DV, Van der Merwe L, Hattingh TL, Nel DG, Moosa MR, S Afr Med J 2009 99 873 875 20459997
3. Acute renal failure. Lameire N, Van Biesen W, Vanholder R, Lancet 2005 365 417 430 15680458
4. Renal acute cellular rejection: correlation between the immunophenotype and cytokine expression of the inflammatory cells in acute glomerulitis, arterial intimitis, and tubulointerstitial nephritis. Sementilli A, Franco M, Transplant Proc 2010 42 1671 1676 10.1016/j.transproceed.2009.11.042 20620497
5. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. Chen YT, Sun CK, Lin YC, Chang LT, Chen YL, Tsai TH, Chung SY, Chua S, Kao YH, Yen CH, Shao PL, Chang KC, Leu S, Yip HK, J Transl Med 2011 9 51 10.1186/1479-5876-9-51 21545725
6. Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. Sun CK, Yen CH, Lin YC, Tsai TH, Chang LT, Kao YH, Chua S, Fu M, Ko SF, Leu S, Yip HK, J Transl Med 2011 9 118 10.1186/1479-5876-9-118 21781312
7. Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin. Yen CH, Lin KC, Leu S, Sun CK, Chang LT, Chai HT, Chung SY, Chang HW, Ko SF, Chen YT, Yip HK, Eur J Pharm Sci 2012 46 455 467 10.1016/j.ejps.2012.03.009 22484332
8. Acute renal failure. Thadhani R, Pascual M, Bonventre JV, N Engl J Med 1996 334 1448 1460 10.1056/NEJM199605303342207 8618585
9. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ, J Am Soc Nephrol 2006 17 1135 1142 10.1681/ASN.2005060668 16495381
10. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A, J Am Soc Nephrol 2007 18 1292 1298 10.1681/ASN.2006070756 17314324
11. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Chen Q, Camara AK, Stowe DF, Hoppel CL, Lesnefsky EJ, Am J Physiol Cell Physiol 2007 292 137 C147 16971498
12. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ, Am J Physiol Cell Physiol 2008 294 460 C466 18077608
13. In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paramagnetic resonance. Hirayama A, Nagase S, Ueda A, Oteki T, Takada K, Obara M, Inoue M, Yoh K, Hirayama K, Koyama A, Am J Physiol Renal Physiol 2005 288 597 F603 10.1152/ajprenal.00020.2004 15536173
14. Favorable balance of anti-oxidant/pro-oxidant systems and ablated oxidative stress in Brown Norway rats in renal ischemia-reperfusion injury. Nilakantan V, Hilton G, Maenpaa C, Van Why SK, Pieper GM, Johnson CP, Shames BD, Mol Cell Biochem 2007 304 1 11 10.1007/s11010-007-9480-z 17458515
15. The role of the mitochondrial permeability transition pore in heart disease. Halestrap AP, Pasdois P, Biochim Biophys Acta 2009 1787 1402 1415 10.1016/j.bbabio.2008.12.017 19168026
16. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. Javadov S, Karmazyn M, Escobales N, J Pharmacol Exp Ther 2009 330 670 678 10.1124/jpet.109.153213 19509316
17. Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Morin D, Assaly R, Paradis S, Berdeaux A, Curr Med Chem 2009 16 4382 4398 10.2174/092986709789712871 19835566
18. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M, J Mol Cell Cardiol 2005 38 367 374 10.1016/j.yjmcc.2004.12.001 15698843
19. 2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Kim JS, Jin Y, Lemasters JJ, Am J Physiol Heart Circ Physiol 2006 290 2024 H2034 10.1152/ajpheart.00683.2005 16399872
20. 2+-induced mitochondrial permeability transition. Argaud L, Gateau-Roesch O, Chalabreysse L, Gomez L, Loufouat J, Thivolet-Bejui F, Robert D, Ovize M, Cardiovasc Res 2004 61 115 122 10.1016/j.cardiores.2003.11.003 14732208
21. Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke. Yuen CM, Sun CK, Lin YC, Chang LT, Kao YH, Yen CH, Chen YL, Tsai TH, Chua S, Shao PL, Leu S, Yip HK, J Transl Med 2011 9 141 10.1186/1479-5876-9-141 21864394
22. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M, N Engl J Med 2008 359 473 481 10.1056/NEJMoa071142 18669426
23. Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction. Sheu JJ, Chua S, Sun CK, Chang LT, Yen CH, Wu CJ, Fu M, Yip HK, Int J Cardiol 2011 147 79 87 10.1016/j.ijcard.2009.08.008 19751953
24. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, Lee FY, Sun CK, Circ J 2008 72 1336 1345 10.1253/circj.72.1336 18654023
25. Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: an echocardiographic, six-month angiographic, and molecular-cellular study. Leu S, Sun CK, Sheu JJ, Chang LT, Yuen CM, Yen CH, Chiang CH, Ko SF, Pei SN, Chua S, Youssef AA, Wu CJ, Yip HK, Int J Cardiol 2011 150 156 168 10.1016/j.ijcard.2010. 03.007 20466442
26. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM, Circulation 2002 106 3009 3017 10.1161/01.CIR.0000043246. 74879.CD 12473544
27. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA, Circulation 2005 112 214 223 10.1161/CIRCULATIONAHA. 104.527937 15998673
28. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O, Scand J Immunol 2003 57 11 20 10.1046/j.1365-3083.2003.01176.x 12542793
29. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD, J Am Coll Cardiol 2005 46 1799 1802 10.1016/j.jacc.2005.07.053 16286162
30. Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling. Shi D, Liao L, Zhang B, Liu R, Dou X, Li J, Zhu X, Yu L, Chen D, Zhao RC, Exp Hematol 2011 39 214 224 e211 10.1016/j.exphem.2010.10.009 21078360
31. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL, J Clin Invest 2002 110 1083 1091 12393844
32. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, Chua S, Fu M, Yip HK, Crit Care Med 2009 37 1197 1205 10.1097/CCM.0b013e31819c0667 19242323